AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 71(2 suppl), 2004, pp. 248-252
Copyright © 2004 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MOREE, M.
Right arrow Articles by EWART, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MOREE, M.
Right arrow Articles by EWART, S.

POLICY CHALLENGES IN MALARIA VACCINE INTRODUCTION

MELINDA MOREE AND SARAH EWART
Malaria Vaccine Initiative, Program for Appropriate Technology in Health, Seattle, Washington

Recently licensed life-saving vaccines have experienced slow introduction and gradual uptake in the developing world. Policy challenges at the national level contribute to the delay in making new vaccines accessible to people in poor countries. The hurdles that delayed the introduction of other vaccines can provide guidance for navigating the policy challenges that face the introduction of a new malaria vaccine. When a malaria vaccine is licensed, national leaders will rely on available data and analyses to draw conclusions about which malaria interventions have the greatest potential for public health impact. Epidemiologic and economic analyses can help facilitate their decision-making. This article draws attention to the importance of research to inform policy decisions and to minimize delays in the introduction of a new malaria vaccine.

Received August 21, 2003. Accepted for publication February 6, 2004.

Authors’ addresses: Melinda Moree and Sarah Ewart, Malaria Vaccine Initiative, Program for Appropriate Technology in Health, 1455 NW Leary Way, Seattle, WA 98107, Telephone: 206-285-3500, Fax: 206-285-6619, E-mail: mmoree{at}path.org.




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
C. Guinovart and P. L. Alonso
Methods for Determining Vaccine Efficacy and Effectiveness and the Main Barriers to Developing a Fully Deployable Malaria Vaccine
Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 276 - 281.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
P. Aide, Q. Bassat, and P. L Alonso
Towards an effective malaria vaccine
Arch. Dis. Child., June 1, 2007; 92(6): 476 - 479.
[Full Text] [PDF]

Home page
 Health Aff (Millwood)Home page
J. Milstien, R. A. Cash, J. Wecker, and D. Wikler
Development Of Priority Vaccines For Disease-Endemic Countries: Risk And Benefit
Health Aff., May 1, 2005; 24(3): 718 - 728.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
J. G. BREMAN, M. S. ALILIO, and A. MILLS
CONQUERING THE INTOLERABLE BURDEN OF MALARIA: WHAT'S NEW, WHAT'S NEEDED: A SUMMARY
Am J Trop Med Hyg, August 1, 2004; 71(2_suppl): 1 - 15.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Society of Tropical Medicine and Hygiene.